MAPT and Alzheimer disease: Genistein could significantly improve the PC12 cell survival rate, reduce the cell damage and apoptosis, and significantly down-regulate the expression of mRNA and the protein levels of CaM, CaMKK, CaMKIV, and tau protein in this cellular model of AD.